Subdividing the COPD group based on plasma HA levels below and above the median of 8.0 ng/ml did not reveal any differences in HAS-3 (p = 0.497) or HYAL-2 (p = 0.219) expression. This evidence concerns the gene HYAL2 and chronic obstructive pulmonary disease.